6,085
Views
20
CrossRef citations to date
0
Altmetric
Editorial

The relationship between vitamin D and obesity

, &
Pages 1197-1199 | Accepted 26 Feb 2014, Published online: 18 Mar 2014

References

  • James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-52
  • Branca F, Nikogosia H, Lobstein T. (eds) The Challenge of Obesity in the WHO European Region and the Strategies for Response. Summary. World Health Organization, 2007
  • Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9
  • Clinical guidelines on the identification, evaluation, treatment of overweight and obesity in adults – the evidence report. National Institutes of Health. Obes Res 1998;6(Suppl 2):51-209S
  • Kienreich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients 2013;5:3005-21
  • Abu El Maaty MA, Hassanein SI, Hanafi RS, et al. Insights on vitamin D's role in cardiovascular disease: investigating the association of 25-hydroxyvitamin D with the dimethylated arginines. J Nutr Sci Vitaminol (Tokyo) 2013;59:172-7
  • Siadat ZD, Kiani K, Sadeghi M, et al. Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors. J Res Med Sci 2012;17:1052-5
  • Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008;52:828-32
  • Khan H, Kunutsor S, Franco OH, et al. Vitamin D. Type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013;72:89-97
  • Ford ES, Ajani UA, Mcguire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30
  • Hypponen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298-305
  • Cimbek A, Gursoy G, Kirnap NG, et al. Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. J Res Med Sci 2012;17:1119-23
  • Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc 2013;88:720-55
  • Manchanda PK, Bid HK. Vitamin D receptor and type 2 diabetes mellitus: growing therapeutic opportunities. Indian J Hum Genet 2012;18:274-5
  • Vinh Quoc Lu'o'ng K, Nguyen LT. The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr J 2013;12:89 . doi:10.1186/1475-2891-12-89
  • Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89:1321-7
  • Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008;159:675-84
  • Boon N, Hul GB, Sicard A, et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 2006;14:1739-46
  • Jorde R, Sneve M, Torjesen P, et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-72
  • Lumb GA, Mawer EB, Stanbury SW. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man. Am J Med 1971;50:421-41
  • Mawer EB, Backhouse J, Holman CA, et al. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 1972;43:413-31
  • Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81
  • Heaney RP, French CB, Nguyen S, et al. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr 2013;4:303-10
  • Schottker B, Herder C, Rothenbacher D, et al. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol 2013;28:267-75
  • Hutchinson MS, Figenschau Y, Almas B, et al. Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes – the Tromso OGTT-study. Int J Vitam Nutr Res 2011;81:317-27
  • Nazarian S, St Peter JV, Boston RC, et al. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res 2011;158:276-81
  • Liel Y, Ulmer E, Shary J, et al. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199-201
  • Hyldstrup L, Andersen T, Mcnair P, et al. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh) 1993;129:393-8
  • Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3
  • Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-9
  • Taheri E, Saedisomeolia A, Djalali M, et al. The relationship between serum 25-hydroxy vitamin D concentration and obesity in type 2 diabetic patients and healthy subjects. J Diabetes Metab Disord 2012;11:16 . doi:10.1186/2251-6581-11-16
  • De Pergola G, Nitti A, Bartolomeo N, et al. Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. Biomed Res Int 2013;2013:921348 . doi:10.1155/2013/921348
  • Buffington C, Walker B, Cowan GS Jr, et al. Vitamin D deficiency in the morbidly obese. Obes Surg 1993;3:421-4
  • Hey H, Stokholm KH, Lund B, et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 1982;6:473-9
  • Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-61
  • Salekzamani S, Neyestani TR, Alavi-Majd H, et al. Is vitamin D status a determining factor for metabolic syndrome? A case–control study. Diabetes Metab Syndr Obes 2011;4:205-12
  • Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-88S
  • Mcgill AT, Stewart JM, Lithander FE, et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008;7:1-5
  • Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007;26:573-80
  • Stokić E, Tomić-Naglić D, Kovačev Zavišić B, et al. Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile. Angiology 2014; in press. doi:10.1177/0003319714528569
  • Wamberg L, Kampmann U, Stodkilde-Jorgensen H, et al. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels – results from a randomized trial. Eur J Intern Med 2013;24:644-9
  • Major GC, Alarie F, Dore J, et al. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007;85:54-9
  • Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5
  • Tai K, Need AG, Horowitz M, et al. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008;24:279-85
  • Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29
  • Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9
  • Reis JP, Von Muhlen D, Miller ER 3rd, et al. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124:e371-9
  • Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke 2006;37:243-5
  • Katsiki N, Athyros VG, Karagiannis A, et al. Vitamin D deficiency, statin-related myopathy and other links with vascular risk. Curr Med Res Opin 2011;27:1691-2
  • Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-80
  • Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11
  • Alhamad HK, Nadukkandiyil N, El-Menyar A, et al. Vitamin D deficiency among the elderly: insights from Qatar. Curr Med Res Opin 2014;30:1189-96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.